Squamous Cell Carcinoma of the Larynx
📧 Sign up to get email alerts when something new happens for Squamous Cell Carcinoma of the Larynx.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: Trial of Stereotactic HYpofractionateD RadioAblative (HYDRA) Treatment of Laryngeal Cancer [Phase 1]
This clinical trial update describes a Phase 1 study of stereotactic hypofractionated radioablation (HYDRA) treatment for laryngeal cancer, …
-
CLINICAL_TRIALS research · 2026-03-13Clinical Trial Update: De-Intensification of Postoperative Radiotherapy in Patients With Squamous Cell Carcinoma of the Head and Neck [Phase 2, Phase 3]
A Phase 2/Phase 3 trial is evaluating de-intensification of postoperative radiotherapy for head and neck squamous cell carcinomas, including…
-
CLINICAL_TRIALS research · 2026-02-10Clinical Trial Update: Transoral Robotic Surgery in Treating Patients With Benign or Malignant Tumors of the Head and Neck [NA]
This clinical trial update indicates that a study evaluating transoral robotic surgery for benign or malignant head and neck tumors is curre…
-
CLINICAL_TRIALS research · 2025-07-24Clinical Trial Update: Testing the Safety of Giving a Standard Dose of Radiation Over a Shorter Period of Time for Patients Who Had Surgery for Intermediate-Risk Head and Neck Cancer [Phase 1]
Phase 1 clinical trial assessing the safety of delivering a standard dose of radiation over a shorter period after surgery for intermediate-…
-
CLINICAL_TRIALS research · 2025-02-26Clinical Trial Update: Fluorescence-guided Surgery in Laryngeal- and Hypopharyngeal Cancer: a Feasibility Trial [Phase 2]
A Phase 2 feasibility trial evaluating fluorescence-guided surgery for squamous cell carcinoma of the larynx and hypopharynx; the study is c…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2024-11-13Clinical Trial Update: Head and Neck Carcinoma Clinical Research Platform for Molecular and Blood-based Biomarkers, Treatment and Outcome
Clinical trial platform in head and neck carcinoma focusing on molecular and blood-based biomarkers, treatment, and outcomes is currently re…
-
CLINICAL_TRIALS research · 2024-09-26Clinical Trial Update: SBRT Followed by Chemoimmunotherapy of Toripalimab Plus Docetaxel and Cisplatin for Larynx Preservation in Patients with Locally Regionally Advanced Squamous Cell Carcinoma of the Larynx and Hypopharynx [Phase 2]
A Phase 2 trial evaluating SBRT followed by chemoimmunotherapy with toripalimab, docetaxel, and cisplatin to preserve the larynx in patients…